Lactic Acid in Skincare: Formulation and Sample Evaluation for Brands
Quick answer: what is lactic acid in skincare?
Lactic acid is an alpha hydroxy acid (AHA). Its chemical name is 2-hydroxypropanoic acid. In skincare it can do three different jobs:
- Adjust pH. FDA's page on alpha hydroxy acids notes that AHAs are sometimes used in cosmetics "to adjust the pH".
- Support hydration and skin feel, often with its salt, sodium lactate. Ingredient inventories list lactic acid with humectant, buffering and skin-conditioning functions.
- Exfoliate. FDA says AHA products cause shedding of surface skin, and that the extent "depends on the type and concentration of the AHA, its pH, and other ingredients in the product."
The ingredient list does not show which job it is doing. "Lactic Acid" can appear on a shower gel that needed a pH adjustment and on a leave-on resurfacing toner. So the first question for a brand is not "how much lactic acid?" It is what lactic acid is supposed to do in this product. That answer decides the raw material, the numbers on the sample sheet, how samples are compared and which claims can be planned.
This guide is for brands briefing a manufacturer, not consumer advice. Our guide to glycolic acid in skincare already covers raw-material strength, finished-formula content, final pH, the US sunburn alert and packaging stability for an AHA product. This article does not repeat that. It covers what is particular to lactic acid: its several roles, its relationship with sodium lactate and how to brief each role.
Section summary: Decide lactic acid's role before you brief. Each role needs different documents, samples and evidence.
Lactic acid and sodium lactate: two ingredients, one system
The chemistry in brief
Lactic acid has the formula C3H6O3 and a molecular weight of about 90, according to PubChem. Sodium lactate is its sodium salt, sodium 2-hydroxypropanoate, with a molecular weight of about 112 (PubChem). PubChem lists the pKa of lactic acid as 3.86 at 20 °C.
In a simple, dilute water solution, about half is free (un-ionized) lactic acid and half lactate at a pH equal to the pKa, with free acid dominating below it. Finished products are rarely that simple. The Cosmetic Ingredient Review (CIR) Expert Panel's 1998 safety assessment of glycolic and lactic acid states that the relationship between free acid, pH and total AHA concentration "may not be calculated simply" from the standard Henderson-Hasselbalch equation, and that partitioning between the oil and water phases of an emulsion must also be considered. Use the pKa to see why pH matters, not to calculate a product's free acid or predict its effect. Acid and salt together can also act as a buffer.
Lactic acid vs sodium lactate: why the difference matters to a buyer
The two have different INCI names and are declared separately.
- Lactic acid lowers pH. At a meaningful level and a low enough pH, it is the ingredient associated with AHA exfoliation.
- Sodium lactate is the salt, not the acid. It is commonly used as a humectant and as the salt half of a lactate buffer. With other conditions unchanged, adding it can change a formula's buffering and pH; the measured finished product shows by how much. On its own, it is no reason to call a product exfoliating.
The salt still matters for safety and labeling. FDA's AHA labeling guidance says the human UV studies reviewed covered glycolic and lactic acid "as well as salts and esters", including sodium lactate, and the CIR conclusion it quotes covers "Glycolic and Lactic Acid, their common salts and their simple esters". That scope does not show that sodium lactate alone increases sun sensitivity or that every product containing it needs a sunburn alert. FDA's guidance is a scoped US recommendation, not a global legal rule. Whether AHA labeling applies to a product with sodium lactate alone, or with lactic acid only for pH adjustment, is for regulatory review in each destination market.
How inventories classify lactic acid
The European Commission’s current CosIng ingredient entries list lactic acid with buffering, humectant and skin-conditioning functions, and sodium lactate with buffering, humectant and keratolytic functions. These are ingredient-inventory functions, not proof that a finished product delivers a benefit, or approval of a formula or claim. A 2021 EU Joint Research Centre preliminary report for the EU Ecolabel revision analysed 44,552 skin care products launched in Europe from 2015 to 2018 (Mintel GNPD data). It placed both lactic acid and sodium lactate in its humectant and exfoliant tables, noting that "ingredients can have different associated functions". It is a preliminary ecolabel report, not a regulatory list, cited only to show that lactic acid is classified in more than one role.
Section summary: Lactic acid and sodium lactate are separate INCI ingredients whose balance depends on pH and the rest of the formula, so measure rather than calculate. The US AHA review included lactate salts, but product labeling is a market-by-market regulatory decision.
Identify the role before you write the brief
An ingredient list shows neither how much lactic acid a product contains nor why it is there. Position is not a reliable guide either. FDA's Cosmetics Labeling Guide explains that US ingredient declarations run in descending order of predominance, but ingredients present at not more than 1% may be listed in any order after those above 1%.
To judge the role, ask the supplier or manufacturer for:
- a written function for lactic acid and every other acid or salt on the formula sheet;
- the content of each, on a stated raw-material and finished-formula basis;
- the measured final pH of the finished product;
- the intended use: leave-on or rinse-off, frequency and contact time;
- any test data or claim support held or proposed for the finished formula.
Without these, the brief is not ready. Roles can also shift during development. A hydration serum reformulated to a lower pH, for example, may need reassessment for exfoliation, tolerance and labeling based on finished-formula conditions. Treat a change like that as a new brief.
Section summary: Get each acid's function, content basis, final pH and intended use in writing. The INCI list cannot show them.
A brand brief table, split by goal
For each lactic acid role, the table shows what to ask, what to record and what still needs proof. A raw material's listed function never settles what the finished product does.
Swipe horizontally to compare the columns.
| Brief goal | Ask the supplier or manufacturer | Record for each sample | Still needs finished-product evidence |
|---|---|---|---|
| pH adjustment only | Why lactic acid rather than another adjuster; target pH range; whether your regulatory reviewer treats it as an AHA ingredient for labeling | Lactic acid input; target and measured pH with date; other acids or buffers | pH stability in the final pack; AHA labeling per market. No exfoliation or skin-benefit claim follows from this role |
| Hydration or skin-feel system (lactic acid and/or sodium lactate) | Grade and assay of each input; the acid-to-lactate ratio and why; expected final pH and buffering | Each input on its own basis; measured pH; notes on tack, after-feel and tingle | A finished-product study for any hydration or skin-feel claim, for example instrumental hydration measurement scoped with a qualified provider; tolerance separately |
| Exfoliation as a stated goal | Proposed content and basis; target pH; the rest of the acid system; designed frequency and contact time; market rules checked | Content and basis; measured pH; frequency and contact time in draft directions; all other acids and strong actives | Finished-product evidence for the exact exfoliation, texture or tone wording; tolerance at the claimed frequency; sun-labeling decisions per market |
The middle row is the one most often under-briefed. A "hydrating acid" story rests on the finished product's data, not on the ingredient's humectant listing. If the finished hydration product has a low measured pH, ask whether it needs assessment for exfoliation, tolerance and labeling, even if you make no exfoliation claim.
Section summary: Write one brief per goal; the evidence each needs is different.
Recording lactic acid and sodium lactate on the sample sheet
The glycolic acid guide explains why raw-material strength, formula content and final pH are separate numbers. Lactic acid cosmetic formulation adds a layer, because sodium lactate may be present.
Raw-material form. PubChem notes that lactic acid "is usually available in solutions containing 50 to 90% lactic acid", so "lactic acid 5%" on a formula line may mean 5% of a solution grade. Sodium lactate is also supplied as a solution. Ask for grade code, certificate of analysis (COA) assay and lot number for each.
One stated basis. Ask for lactic acid and sodium lactate inputs each as % w/w on a 100% basis from supplier assay, and, if you want one comparable number, total lactate as a lactic acid equivalent with the calculation shown. Any consistent basis works. Changing basis between versions breaks the comparison.
Final pH, measured and dated. A 1998 double-blind, randomized, placebo-controlled study by Thueson and colleagues in 26 female subjects measured epidermal renewal after 10% lactic acid at pH 2.0, 3.0 and 4.0, and 5%, 10% and 15% at pH 3.0. The abstract reports the effect as "highly pH dependent" at fixed concentration and concentration dependent at fixed pH, and suggests free acid concentration is what matters. The first author was affiliated with Cosmederm Technologies. Several tested conditions sit outside the CIR cosmetic conditions discussed below, and the study says nothing about any specific product. For a buyer the lesson is narrow: record both percentage and pH.
Changing sodium lactate can change more than humectancy. With other conditions unchanged, it may shift the formula's pH and buffering. Ask for a new measured pH with every change rather than assuming the direction or size of the shift.
Section summary: Fix one basis per input and re-measure pH whenever sodium lactate changes.
Three product forms and their questions
These are product forms a brand might ask a manufacturer to develop, not existing GZ Cosmetics Lab formulas; nothing here implies a set concentration, availability or test result.
Single-acid leave-on product
A toner, serum or night lotion with lactic acid as the only exfoliating acid.
- Content and pH together. Ask how both were chosen for the intended frequency.
- The buffer. Ask the level of sodium lactate or other base, and why. Buffering is one of the formula variables that samples and evidence have to judge.
- Schedule. "Nightly" and "two or three evenings a week" are different briefs; directions, warnings and tolerance evidence follow from it.
Multi-acid product that includes lactic acid
Lactic acid combined with another AHA, a BHA such as salicylic acid, or a polyhydroxy acid.
- Each acid's role. "Lactic for hydration, glycolic for exfoliation" is a hypothesis to be shown on the finished product.
- Cumulative exposure. Ask how the combination, final pH and directions were judged for the intended frequency, and what tolerance evidence is proposed for the finished formula. Each acid being within its own guideline does not make the mixture suitable.
- Separate market rules. Salicylic acid has its own conditions and claim limits; see our guide to salicylic acid in skincare.
- Claims follow the product. "Triple acid" states composition; effect claims need evidence on the combination.
Rinse-off product containing lactic acid
A cleanser, body wash or wash-off mask.
- Exfoliation or pH? Ask which, and get the answer on the formula sheet. If you want an exfoliation claim, brief it; short contact and rinsing limit what the acid can do, and the claim needs evidence on the cleanser itself.
- Contact time. "Massage and rinse" and "leave for a few minutes" are different products. FDA's guidance recommends its sunburn alert for "discontinuous use" products too, meaning those left on skin under an hour and then rinsed, when used on sun-exposed skin.
- Surfactants and preservation at that pH. Ask how both were set, and what preservative efficacy work is planned for the final formula in its pack.
Section summary: Each form raises its own questions: buffer and schedule, cumulative exposure, or contact time.
Lactic acid vs glycolic acid: what a brand can and cannot conclude
Lactic acid is often called "gentler" or "more hydrating" than glycolic acid, usually because its molecule is larger (molecular weight about 90 against about 76). That is too simple for a specification or a claim. FDA says exfoliation depends on AHA type, concentration, pH and the other ingredients, so type is one factor of four. Molecular weight, pH, buffering and the rest of the formula together shape how a finished product performs, so do not assume lactic acid is naturally gentler.
What a brand can do:
- Compare like with like. Ask for lactic and glycolic versions with stated content, basis and measured pH, in the same base and pack.
- Treat "gentler" as a result to test, through tolerance evidence on the finished product in your intended users and schedule.
- Treat "more hydrating" the same way. A hydration claim needs a hydration study on the finished product.
FDA's AHA page reports the CIR conclusion that products containing glycolic and lactic acid are safe for consumers at an AHA concentration of 10% or less, a final pH of 3.5 or greater, and with formulation or directions addressing sun sensitivity. The conditions are the same for both acids. They are a CIR safety assessment cited by FDA, not a US legal limit, not a rule elsewhere and not a product specification. They give no basis for briefing more lactic acid "because it is milder".
Section summary: Compare matched samples and test any "gentler" claim.
Sample review: what to compare and what to leave open
Use unique version codes and the same storage, pack and applicator for every comparison. Then add two lactic acid checks.
Role drift. At each revision, compare the formula sheet with the role in the brief. A pH adjuster whose lactic acid input has crept up, or a hydration product whose pH has dropped, needs discussing before the next round.
Sensory notes are not tolerance data. A tingle noticed by the brand team describes sensory fit only. Informal tests on staff or friends do not replace a designed study.
A bench review shows whether the sample matches its sheet and looks, smells and feels acceptable on the day. It cannot show shelf-life behavior, pack compatibility over time, tolerance at the claimed frequency or any skin benefit. Ask which of these the manufacturer proposes to scope, and do not assume a test, duration or result is included unless the quotation says so.
Section summary: Check role drift at every revision. Bench samples show fit, not stability, tolerance or efficacy.
Illustrative example: choosing between two lactic acid briefs
Fictional, illustrative example. The brand, products and conversations are invented. It does not describe a real client, test, quotation, GZ Cosmetics Lab formula or stock product.
"Brand M" plans a lactic acid product for a first US launch and has two ideas:
- Brief A, hydrating serum. Leave-on, lactic acid with sodium lactate in a humectant base; intended claim about skin feeling hydrated and soft.
- Brief B, resurfacing toner. Leave-on, two or three evenings a week, lactic acid as the only exfoliating acid; intended claim about smoother-looking skin.
Brand M asks a prospective manufacturer the same questions about both:
Swipe horizontally to compare the columns.
| Question Brand M asked | Brief A: hydrating serum | Brief B: resurfacing toner |
|---|---|---|
| What is lactic acid doing? | Humectant and buffer system with sodium lactate; manufacturer to say whether it also exfoliates at the proposed pH | Intended exfoliant |
| How is content recorded? | Each input separately, 100% basis from supplier assay | Lactic acid input, 100% basis from supplier assay |
| What sets final pH? | Acid-to-lactate ratio; manufacturer proposes and explains a range | Chosen with content for the schedule and named markets |
| US sunburn alert? | Open; regulatory reviewer decides | Likely within FDA's recommendation; regulatory reviewer confirms |
| Evidence for the claim? | Finished-product hydration study | Finished-product appearance study plus tolerance at the stated frequency |
| What the bench sample shows | Texture, tack, after-feel, pH match | Feel on application, tingle (sensory only), pH match |
Decision. Brief B needs exfoliation evidence, a tolerance plan and sun-protection directions; Brief A needs a hydration study and a labeling answer. Brand M chooses Brief A for development, pending labeling review and claim evidence, and parks Brief B.
Follow-up questions. Before samples, Brand M asks the manufacturer to (1) propose a final pH range for Brief A and say whether the formula is expected to exfoliate at that pH; (2) list every acid and salt with its function; (3) give each version a new code and measured pH; and (4) say which stability, preservation, compatibility and claim studies it recommends and which are quoted separately.
Claims: keep each line tied to the role
Plan claims by role, then check each line's wording, evidence and destination market.
- Composition ("with lactic acid", "contains AHA"): formula and raw-material documents, matching the INCI list. If lactic acid only adjusts pH, a front-of-pack "AHA" call-out implies a benefit the product was not designed for.
- Hydration and skin feel: finished-product evidence suited to the wording. An inventory humectant listing does not substantiate it.
- Appearance linked to exfoliation (smoother-looking, more even-looking skin): finished-product evidence for that claim, plus a market check of the wording.
- "Gentle", "daily", "for sensitive skin": evidence designed for the users and frequency claimed.
- Outside a cosmetic: FDA treats products intended to treat or prevent disease, or affect the structure or function of the body, as drugs, naming acne treatments and skin lighteners. It also notes that the more serious AHA adverse reactions appear most often with the most exfoliating products, such as "skin peelers". Keep acne, lightening, scar-removal and peel language out of a cosmetic brief.
Our guide to cosmetic efficacy testing explains how to match a claim to an endpoint and brief a study on the finished product.
Section summary: Documents support composition claims; finished-product evidence supports everything else.
Inquiry and sample review checklist
Use this list at inquiry and as each sample arrives. Each item is a question for the manufacturer or your regulatory and testing partners, not a description of what any manufacturer, including GZ Cosmetics Lab, has committed to provide.
- Role statement: function of lactic acid and every other acid or salt, on the formula sheet.
- Raw-material identity: INCI name, supplier, grade code, form (for example solution), assay, COA and lot number, for lactic acid and any sodium lactate.
- Origin documents: lactic acid is made commercially by fermentation or a synthetic route (PubChem); for origin wording, ask the supplier to document the route for your grade.
- Content basis: one basis for each lactate input, unchanged across versions, plus an optional lactic acid equivalent with the calculation shown.
- Final pH: target range and dated measurement per sample code; re-measured when a buffer changes.
- Frequency and contact time: leave-on or rinse-off, how often, how long, in draft directions.
- Other actives: full list, so cumulative exposure can be reviewed.
- Version codes: a new code per revision; old records kept.
- Stability and pack compatibility: proposed parameters (for example pH, appearance, odor, viscosity) in the final pack and recommended compatibility work, with conditions and durations stated in the proposal.
- Preservation: how preservative performance will be confirmed.
- Tolerance: evidence proposed for your users and schedule, who runs it, and whether it is quoted.
- Labeling per market: whether US AHA sun-sensitivity wording applies (including for sodium lactate or pH-adjusting use), and which current legal texts were checked elsewhere.
- Claim basis: for each line, the planned evidence and the decision to keep, narrow or drop it.
What to send in your brief
A useful lactic acid brief fits on one page:
- Product and format, with pack direction.
- Primary role of lactic acid: pH adjustment, hydration or skin-feel system, or exfoliation.
- Users and schedule, leave-on or rinse-off.
- Destination markets.
- Draft claims, word for word, so evidence can be planned early.
- Other actives in the formula or routine.
- What you want quoted: samples only, or samples plus stability, preservation, compatibility, tolerance and claim studies.
Leave concentration and pH open unless you have a reason to fix them, and ask the manufacturer to propose both with the basis and markets checked.
When the brief is ready, send it through our quote request form.
Key takeaways
- Lactic acid in skincare can adjust pH, support hydration with sodium lactate, or exfoliate; the INCI list does not say which.
- Record lactic acid and sodium lactate separately on a fixed basis, and measure final pH every time.
- The US AHA safety review covered lactate salts, but labeling for a given product is a regulatory decision per market.
- "Gentler" or "more hydrating" than glycolic acid must be shown on the finished product.
- Composition claims need documents; benefit and tolerance claims need finished-product evidence.
Frequently asked questions
Does lactic acid make our cleanser exfoliating? Not necessarily, and the ingredient list cannot tell you. Ask for its function, content, final pH and contact time. For an exfoliation claim, brief that role and plan evidence on the cleanser itself.
What concentration should we ask for? Ask the manufacturer to propose content and pH together for your role, format, schedule and markets, with the basis written out.
Does the US sunburn alert apply if lactic acid only adjusts pH? Ask your regulatory reviewer. FDA's guidance excludes AHAs present only as incidental ingredients, which it describes, citing 21 CFR 701.3(l), as present at insignificant levels with no technical or functional effect. Because adjusting pH is a technical function, do not assume the exclusion applies without that review. Other markets set their own rules.
Sources
- European Commission. CosIng: Lactic Acid (ingredient entry). https://ec.europa.eu/growth/tools-databases/cosing/details/34809
- European Commission. CosIng: Sodium Lactate (ingredient entry). https://ec.europa.eu/growth/tools-databases/cosing/details/79577
- U.S. Food and Drug Administration. "Alpha Hydroxy Acids." Content current as of 11/22/2022. https://www.fda.gov/cosmetics/cosmetic-ingredients/alpha-hydroxy-acids
- U.S. Food and Drug Administration. "Guidance for Industry: Labeling for Cosmetics Containing Alpha Hydroxy Acids." January 2005; page content current as of 11/13/2018. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/guidance-industry-labeling-cosmetics-containing-alpha-hydroxy-acids
- Thueson DO, Chan EK, Oechsli LM, Hahn GS. "The roles of pH and concentration in lactic acid-induced stimulation of epidermal turnover." Dermatologic Surgery 24(6):641–645, 1998. Abstract. https://pubmed.ncbi.nlm.nih.gov/9648571/
- Faraca G. et al. "Revision of the EU Ecolabel Criteria for Cosmetic Products and Animal Care Products (previously Rinse-off Cosmetic Products): Preliminary Report." European Commission Joint Research Centre, EUR 30809 EN, September 2021. Preliminary ecolabel report, not a regulatory list. https://publications.jrc.ec.europa.eu/repository/handle/JRC126061
- Cosmetic Ingredient Review Expert Panel. "Final Report on the Safety Assessment of Glycolic Acid, … and Lactic Acid, … Sodium … Lactates …" International Journal of Toxicology 17 (Suppl. 1), 1998. https://cir-reports.cir-safety.org/view-attachment/?id=262ce2bc-8d74-ec11-8943-0022482f06a6
- U.S. Food and Drug Administration. "Cosmetics Labeling Guide." https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/cosmetics-labeling-guide
- National Center for Biotechnology Information. PubChem Compound Summary: Lactic Acid (CID 612). https://pubchem.ncbi.nlm.nih.gov/compound/Lactic-Acid
- National Center for Biotechnology Information. PubChem Compound Summary: Sodium Lactate (CID 23666456). https://pubchem.ncbi.nlm.nih.gov/compound/Sodium-Lactate
Ready to Start Your Project?
Tell us your product requirements. Within 24 hours, our technical team will reply with a quotation or the questions needed to prepare one.